Abstract
Emergent economically important diseases affecting the poultry industry in the face of commercial vaccination programs in place might require custom-made vaccines to be controlled in the field. These custom-made vaccines (“autogenous”), albeit requiring less regulatory burden than fully licensed commercial vaccines, are restricted in their scope and field isolates and can only be used in particular areas/operations. This chapter summarizes field and research experience of the author with some viral and bacterial autogenous vaccine programs (e.g., Avian Reovirus, Fowl Adenovirus, Infectious Bursal Disease Virus, Salmonella enterica spp., Escherichia coli, Clostridium spp.), as well as commentaries on regulations, and adjuvant technologies used in the poultry industry.
Reference85 articles.
1. Collett SR, Smith JA, Boulianne M, Owen RL, Gingerich E, Singer RS, et al. Principles of disease prevention, diagnosis, and control. In: Swayne DE, Boulianne M, Logue CM, McDougald LR, Nair V, Suarez DL, et al, editors. Diseases of Poultry. Hoboken, NJ: Wiley-Blackwell; 2020
2. Martin M. Biosecurity and Disease Control - the Problems Defined. In: Owen RL, American Association of Avian Pathologists, editors. A Practical Guide for Managing Risk in Poultry Production. 2nd ed. Jacksonville, FL: AAAP, Inc; 2017. pp. 10-21
3. Racicot M, Vaillancourt J-P. Biosecurity & Poultry Production. In: Manual of Poultry Diseases. Paris, France: The French Association for the Advancement of Sciences (AFAS); 2015. pp. 553-561
4. Stokstad E. Deadly bird flu establishes a foothold in North America. Science. 2022;377:912. DOI: 10.1126/science.ade5542
5. Abdul-Cader MS, Palomino-Tapia V, Amarasinghe A, Ahmed-Hassan H, De Silva Senapathi U, Abdul-Careem MF. Hatchery vaccination against poultry viral diseases: Potential mechanisms and limitations. Viral Immunology. 2018;31:23-33. DOI: 10.1089/vim.2017.0050